COMPANY

LifeLens Technologies

Location: Ivyland, PA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $21.1M (Form D filed Nov 17, 2025; amended Sep 8, 2026). SEC Form D 0001782780-25-000002 (Nov 17, 2025)
Evidence (1 event)
- Nov 17, 2025 · SEC Form D 0001782780-25-000002
  Name of Issuer: LifeLens Technologies, Inc.; CIK: 1782780; Address: Ivyland, PA; Submission type: D; Filing date: 2025-11-17; Industry Group: Other Technology; Date of First Sale: 2025-11-04; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 23171697; Total Amount Sold: 15079197; Federal exemptions: 06b || Name of Issuer: LifeLens Technologies, Inc.; CIK: 1782780; Address: Ivyland, PA; Submission type: D/A; Filing date: 2026-09-08; Industry Group: Other Technology; Date of First Sale: 2025-11-04; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 40000000; Total Amount Sold: 21104217; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Jul 9, 2026 FDA FDA 510(k) clearance: LifeLens Physiological Monitor — K260157, Jul 9, 2026. Applicant at approval: LifeLens Technologies, Inc. source ↗

Jul 9, 2026 FDA 510(k) clearance: LifeLens Physiological Monitor — K260157, Jul 9, 2026. Applicant at approval: LifeLens Technologies, Inc. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12